NCT06153134View on ClinicalTrials.gov

Curcuma Xanthorriza Roxb. 10% Cream for Melasma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

February 22, 2024

Study Completion Date

May 22, 2024

Conditions
Melasma
Interventions
DRUG

10% Curcuma xanthorriza Roxb.

Patients in experimental arms will receive 10% Curcuma xanthorriza Roxb. cream for 2 months

DRUG

2% Kojic Acid

Patients in experimental arms will receive 2% Kojic Acid cream for 2 months

Trial Locations (1)

40161

RECRUITING

Hasan Sadikin General Hospital, Bandung

All Listed Sponsors
lead

Universitas Padjadjaran

OTHER